New hope for stubborn psoriasis spots
NCT ID NCT05938361
Summary
This study is testing how well the drug tildrakizumab works for psoriasis that appears in hard-to-treat areas like the scalp, nails, genitals, palms, and soles. It will involve 120 adults in France who have these specific types of psoriasis. The main goal is to see how much the psoriasis improves in these areas over one year of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS PALMARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Dermatologie- Hopital Saint Joseph
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.